A Study of Mycophenolate Mofetil and Cyclosporin, Without Concomitant Corticosteroids, After a First Renal Transplant

Exclusion Criteria

• •Women who are pregnant or breast-feeding
• •Patient with an immunological risk considered high and defined as a percentage of anti-HLA antibodies of ³20% (previous or recent determination of T lymphocytes)
• •Patient with a history of allergy to rabbit proteins
• •Cold ischaemia time of more than 36 hours
• •Patient allergic to macrolide antibiotics, to tacrolimus or to MMF
• •Patient on immunosuppressant treatment before transplantation
• •Patient suffering from a malignant neoplasm or with a history of malignant neoplasia, with the exception of treated baso- or spinocellular cancers
• •Patient waiting for another transplant in addition to the kidney
• •Patient who has already received an organ or tissue graft
• •Leukocyte count \<2000/mm3 and/or platelet count \<50 000/mm3
• •Patient suffering from focal glomerulonephritis